Scalper1 News
Shares of specialty drugmaker Horizon Pharma (HZNP) were down 30% on the stock market today after two major pharmacy benefit managers removed its drugs from their formularies. Horizon disclosed in an SEC filing that Express Scripts (ESRX) and Caremark, CVS’ (CVS) PBM division, are removing its drugs Duexis and Vimovo from their formularies as of August and will place the drugs on their exclusion lists at the start of next year. Horizon said this Scalper1 News
Scalper1 News